The New York Stock Exchange welcomes Johnson & Johnson.
New York Stock Exchange
Johnson & Johnson Announced on Monday that it was working with Nvidia Develop and expand new artificial intelligence surgical applications.
Kimberly Powell, vice president of healthcare at Nvidia, said Johnson & Johnson’s medical technology unit and Nvidia plan to integrate artificial intelligence into devices and platforms from pre- to post-operative to help ensure that surgeons have all the information they need. For example, these companies are using artificial intelligence to analyze surgical films and automate the time-consuming documentation required after surgery.
“The ability to use all the data sources in the operating room, whether it’s your voice or video from cameras inside your body or elsewhere, to take advantage of the generative AI moment that we’re in,” Powell told CNBC in an interview.
Johnson & Johnson’s medical technology arm develops tools and solutions for conditions such as heart failure, kidney disease and stroke, and its technology is used in more than 75 million procedures annually, the company told CNBC. Powell said that Nvidia has been working in the field of medical equipment and imaging for more than ten years.
Shan Jegatheeswaran, vice president and global head of digital at Johnson & Johnson MedTech, said one minute of surgical video is equivalent to about 25 CT scans, so having the computing power and infrastructure to annotate and share these videos widely will be powerful for surgeons.
In the short term, he said, de-identified and enhanced films could help educate and train surgeons. In the longer term, analytics can be overlaid on video to provide real-time decision support. More accessible surgical films mean residents will not have to rely solely on the insight and availability of more experienced physicians at their institution.
“Think about athletes. They watch game tape, and over time when they look at themselves, they get better,” Jegatheeswaran told CNBC. “That’s a starting point. That’s the holy grail in the short term.”
Powell said the collaboration is in the “early stages” and many applications will need time to be fine-tuned and securely implemented. However, she said non-diagnostic use cases such as automating paperwork will help save surgeons time and make a difference “immediately.”
“I think all of us as patients should be very excited that this technology is going to be in the hands and at the fingertips of all clinicians, all hard-working nurses and all health care providers,” Powell said. “They will have the best tools and information.”